Derma Sciences, Inc. and Comvita to Move Forward with MEDIHONEY(TM) Product Line

PRINCETON, N.J.--(BUSINESS WIRE)--Derma Sciences, Inc. (OTCBB: DSCI), a manufacturer and marketer of advanced wound care products, today announced that it and its partner, Comvita New Zealand, Ltd, are changing the brand name of their honey-based product line to MEDIHONEYTM, effective immediately. Previously, both companies had intended to market the products under the API-MEDTM brand. The MEDIHONEYTM brand is an asset Comvita acquired through its recent purchase of Medihoney-Pty Ltd., formerly a subsidiary of the Australian-based Capilano group. MEDIHONEYTM is the market-leading line of Active Leptospermum honey-based wound and burn dressings, and is currently sold throughout Europe, Australia, and New Zealand. The brand has been featured in multiple peer-reviewed journal articles on the use of honey for the management of wounds and burns, with several additional articles set to be published in the fall of 2007.

MORE ON THIS TOPIC